Equity Research Analyst – Biotechnology

LightEdge Asset Management (LEAM) is a global investment firm focused on high-conviction, research-driven opportunities across global markets.LightEdge Asset Management (LEAM) is looking for an Equity Research Analyst with 3–4 years of experience covering the Biotechnology / Biopharma sector, primarily across US and European equities.ResponsibilitiesCover biotech and biopharma companies across the US and Europe.Evaluate clinical pipelines, trial data, catalysts, and competitive positioning.Track FDA, EMA, and other key regulatory developments.Analyze early- to late-stage biotech companies and identify investment opportunities.Translate scientific and clinical developments into clear investment views.Present actionable long and short ideas to the investment team.Requirements3–4 years of direct biotech or biopharma equity research experience.Strong understanding of clinical trials, drug development, and regulatory frameworks.Deep knowledge of US and European biotechnology markets.Strong ability to connect scientific developments with stock-specific investment implications.Proven track record of generating actionable investment ideas.